AL
LIN icon

Aspiriant LLC’s Linde LIN Stock Holding History

Aspiriant LLC’s Portfolio LIN Stock Details LIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$253K Sell
511
-58
-10% -$27.4K 0.01% 305
2025
Q4 		$243K Buy
569
+60
+12% +$25.7K 0.01% 298
2025
Q3 		$242K Sell
509
-63
-11% -$29.8K 0.01% 275
2025
Q2 		$268K Sell
572
-20
-3% -$9.13K 0.01% 271
2025
Q1 		$276K Sell
592
-49
-8% -$22.1K 0.01% 246
2024
Q4 		$268K Buy
641
+121
+23% +$55.1K 0.01% 247
2024
Q3 		$248K Sell
520
-1
-0.2% -$456 0.01% 254
2024
Q2 		$229K Sell
521
-316
-38% -$139K 0.01% 260
2024
Q1 		$389K Sell
837
-161
-16% -$69.7K 0.02% 220
2023
Q4 		$410K Sell
998
-28
-3% -$11K 0.02% 208
2023
Q3 		$382K Buy
1,026
+18
+2% +$6.85K 0.02% 202
2023
Q2 		$384K Sell
1,008
-385
-28% -$141K 0.02% 197
2023
Q1 		$495K Sell
1,393
-3
-0.2% -$1K 0.03% 176
2022
Q4 		$455K Buy
1,396
+286
+26% +$89.6K 0.02% 183
2022
Q3 		$299K Sell
1,110
-21
-2% -$6.03K 0.01% 211
2022
Q2 		$326K Buy
1,131
+6
+0.5% +$1.87K 0.02% 203
2022
Q1 		$360K Sell
1,125
-42
-4% -$13K 0.02% 203
2021
Q4 		$405K Buy
+1,167
New +$378K 0.02% 194
2019
Q3 		– Sell
-1,448
Closed -$289K – 226
2019
Q2 		$289K Sell
1,448
-353
-20% -$66K 0.02% 183
2019
Q1 		$319K Sell
1,801
-821
-31% -$136K 0.03% 175
2018
Q4 		$407K Buy
+2,622
New +$414K 0.03% 156

Other funds holding LIN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Aspiriant LLC's LIN Position: Q1 2026 in Review

Aspiriant LLC reduced its Linde (LIN) stake by 10% in Q1 2026, selling an estimated $27.4K and leaving 511 shares worth $253K. The position accounts for 0.01% of the portfolio, ranked #305.

Aspiriant LLC first reported a position in LIN in Q4 2018 and has held it in 21 quarters since. The position peaked at $495K in Q1 2023. 2,267 funds tracked by Wall St. Rank hold LIN as of Q1 2026.

  • Aspiriant LLC held 511 shares of Linde worth $253K as of Q1 2026.
  • Aspiriant LLC sold 58 Linde shares in Q1 2026, an estimated $27.4K.
  • Linde made up 0.01% of Aspiriant LLC's portfolio in Q1 2026, its #305 holding.
  • Aspiriant LLC first reported a position in Linde in Q4 2018 and has held it in 21 quarters since.
  • Aspiriant LLC's Linde position peaked at $495K in Q1 2023.
  • 2,267 funds tracked by Wall St. Rank held Linde as of Q1 2026.

Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.